Table 2. Frequency of Different Outcome During Follow up .
| First visit | 6 months | 1st year | 2nd year | 3rd year | 4th year | 5th year | 6th year | 7th year | |
|---|---|---|---|---|---|---|---|---|---|
| Inactive Carrier, No. (%) | 51 (18.5) | 49 (17.8) | 44 (16) | 45 (16.4) | 43 (15.6) | 34 (12.4) | 33 (12) | 29 (10.5) | 29 (10.5) |
| CI 95% | 14.1 – 23.7 | 13.5 – 22.9 | 11.9 – 20.9 | 12.2 – 21.3 | 11.6 – 20.5 | 8.7 – 16.8 | 8.4 – 16.4 | 7.2 – 14.8 | 7.2 – 14.8 |
| Chronic Hepatitis, No. (%) | 199 (72.4) | 201 (73.1) | 204 (74.2) | 203 (73.8) | 204 (74.2) | 210 (76.4) | 209 (76.0) | 211 (76.91) | 208 (75.6) |
| CI 95% | 66.7 – 77.6 | 67.4 – 78.2 | 68.6 – 79.3 | 68.2 –78.9 | 68.6 – 79.3 | 70.9 – 81.3 | 70.5 – 80.9 | 71.3 – 81.6 | 70.1 – 80.6 |
| Cirrhosis, No. (%) | 25 (9.1) | 25 (9.1) | 27 (9.8) | 27 (9.8) | 27 (9.8) | 26 (9.8) | 26 (9.5) | 28 (10.4) | 29 (10.5) |
| CI 95% | 6.0 – 13.1 | 6.0 – 13.1 | 6.6 – 14.0 | 6.6 – 14.0 | 6.9 – 14.4 | 6.3 – 13.5 | 6.3 – 13.5 | 6.9 – 14.4 | 7.2 – 14.8 |
| HCC, No. (%) | ---------- | ---------- | --------- | --------- | ---------- | 1 (0.4) | ---------- | ---------- | 1 (0.4) |
| CI 95% | -------- | -------- | -------- | -------- | -------- | 0.01 – 2.0 | -------- | -------- | 0.01 – 2.0 |
| Negative, No. (%) | ---------- | ---------- | ---------- | ---------- | 1 (0.4) | 4 (1.5) | 5 (1.8) | 5 (1.8) | 6 (2.2) |
| CI 95% | -------- | -------- | -------- | -------- | 0.01 – 2.0 | 0.4 – 3.7 | 0.6 – 4.2 | 0.6 – 4.2 | 0.8 – 4.7 |
| Death, No. (%) | ---------- | ---------- | --------- | --------- | ---------- | ---------- | -------- | ---------- | 2 (0.7) |
| CI 95% | -------- | -------- | -------- | -------- | -------- | -------- | --------- | -------- | 0.09 – 2.6 |